TearLab
San Diego
About TearLab
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol TEAR and on the Toronto Stock Exchange under the symbol TLB.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $54.6M
- Funding stage: M&A
- Last round: Post-IPO Debt (Oct 2015)
- Ticker: otcqb:TEAR
- Website: tearlab.com
- Phone: (858)812-0540
Industries & Categories
Hardware, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tearlab-1340738 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.